Print

FDA Mulls Killing GlaxoSmithKline (GSK)'s Avandia Safety Study  
4/19/2010 6:43:40 AM

Reuters -- U.S. regulators are considering ending a safety study on GlaxoSmithKline's (GSK.L) diabetes drug Avandia, the Wall Street Journal reported on Sunday, saying the move could also jeopardize the drug's presence in the U.S market.
//-->